Back
GT Biopharma Vs. Rezolute Industry Stock Comparison
Sell
49
GTBP
GT Biopharma
Last Price:
2.03
Seasonality Move:
-3.67%
Buy
58
RZLT
Rezolute
Last Price:
4.95
Seasonality Move:
-24.13%
Sell
49
GT Biopharma (GTBP)
is a Sell
Is GT Biopharma a Buy, Sell or Hold?
- The current GT Biopharma [GTBP] share price is $2.02. The Score for GTBP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- GTBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Rezolute (RZLT)
is a Buy
Is Rezolute a Buy, Sell or Hold?
- The current Rezolute [RZLT] share price is $4.93. The Score for RZLT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- RZLT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GTBP Stock Price Chart
What is GT Biopharma's stock price today?
-
The GT Biopharma share price today is $2.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing slight selling pressure.
RZLT Stock Price Chart
GTBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 42.95 | Sell |
| Chaikin Money Flow: | -11804 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.03 - 2.19) | Sell |
| Bollinger Bands (100): | (1.93 - 3.53) | Sell |
RZLT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 53.18 | Buy |
| Chaikin Money Flow: | -110625 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.64 - 5.14) | Buy |
| Bollinger Bands (100): | (3.76 - 5.08) | Buy |
GTBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.13 | Sell |
| 20-day SMA: | 2.12 | Sell |
| 50-day SMA: | 2.22 | Sell |
| 200-day SMA: | 3.86 | Sell |
| 8-day EMA: | 2.11 | Sell |
| 20-day EMA: | 2.13 | Sell |
| 50-day EMA: | 2.29 | Sell |
| 200-day EMA: | 4.74 | Sell |
RZLT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.85 | Buy |
| 20-day SMA: | 4.96 | Sell |
| 50-day SMA: | 4.65 | Buy |
| 200-day SMA: | 3.12 | Buy |
| 8-day EMA: | 4.85 | Buy |
| 20-day EMA: | 4.84 | Buy |
| 50-day EMA: | 4.68 | Buy |
| 200-day EMA: | 3.54 | Buy |
GT Biopharma Earnings Growth & GTBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.
Rezolute Earnings Growth & RZLT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.36 per share.
GT Biopharma Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rezolute Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||